Committed to scientific advancement. Passionate about patient care.
At Tolmar, science drives everything we do. Through a relentless focus on technology, science, partnership and excellence, we seek to advance patient care and deliver value through innovative therapies and services.
The Tolmar portfolio includes specialty products for urology, oncology and dermatology. The invention, development and worldwide approval of ELIGARD® (leuprolide acetate for injectable suspension) delivers innovation and commitment to the urology, oncology and hospital communities, providers and patients. Technology-driven development and high-quality manufacturing capabilities established Tolmar as a leading player for topical generics in the field of dermatology.
Our fully integrated model ensures that Tolmar controls all aspects of the research, development, approval and commercialization of our products. With numerous FDA-approved products, we have earned a global reputation for our strict standards, expertise in manufacturing and proven record in regulatory and clinical development. Our robust pipeline harnesses our expertise and experience, and ensures that we will carry this legacy well into the future.
Tolmar is privately held, with an established Commercial presence across the U.S. Our state-of-the-art product development and manufacturing facilities and headquarters are based in Northern Colorado.